Histogen Development and Pipeline Update

Following a strategic evaluation of its regenerative medicine platform technology programs, Histogen announced plans to focus on high-value orthopedic indications for its human extracellular matrix and intradiscal injection products.

Histogen is on track to initiate a Phase I/II clinical study of HST 003 within the month, examining human...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us